Zimmer Biomet Holdings, Inc. (NYSE:ZBH) will look for acquisitions. Bryan Hanson, Chairman, President and Chief Executive Officer said, "From an M&A standpoint, yes, we are clearly in Phase III of the transformation of the company, which I've clearly talked about looks at portfolio transformation focused on getting more revenue and faster growth markets in its simplest form. And that's exactly what we're going to concentrate on.

The fact is, as our balance sheet continues to strengthen, our flexibility, your strategic flexibility goes up. And we will look at acquiring technologies that make sense from a mission standpoint for the company, that we see a path to leadership in, that we think will increase our weighted average market growth because that's important for sustainability and we see a path to be able to increase the growth rate in EPS. And I've said before, there are 3 areas that we'll look at for acquisitions, mainly kind of smaller to midsized deals, but we look at things that would enhance our position in recon in those faster-growth submarkets that could be robotics data or the ASC settings.

In orthopedic areas diversification that would be in vast growth subsegments like Sports or CMFT or Extremities. And then as you said, those things that might be outside of orthopedics that would help us diversify the business away from elected procedures, but also in vast growth markets".